China is a major producer and exporter of cephalosporin APIs and intermediates. Between 2015 and 2024, export revenues in this sector grew from $433 million to $792 million, reflecting a compound annual growth rate (CAGR) of 6.9%.
In the first three quarters of 2024, the total trade volume of pharmaceutical products between China and countries along the 'Belt and Road' (B&R) reached $32.084 billion, marking a year-on-year increase of 3.72%.